Rainbow at shoreline

The Massachusetts ME/CFS & FM Association, a 501(c)3 founded in 1985, exists to meet the needs of patients with ME (Myalgic Encephalomyelitis), CFS (Chronic Fatigue Syndrome) or FM (Fibromyalgia), their families and loved ones. The Massachusetts ME/CFS & FM Association works to educate health-care providers and the general public regarding these severely-disabling physical illnesses. We also support patients and their families and advocate for more effective treatment and research.

Research articles

Pediatric ME/CFS Case Definition

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is not an illness limited to adults. The illness also occurs in both children and adolescents. Although ME/CFS in both children and adults is the same illness syndrome, there are some variations in the symptoms and the course of illness between adults and children. Pediatric ME/CFS can range in severity from mild to moderate ("moderate symptoms at rest that become severe with effort-unable to attend school") to severe ("often housebound or bed-bound").

In a community-based study in Chicago using the 1994 Centers for Disease Control & Prevention (CDC) case definition (Jason et al., 1999; Jordan et al., 2006) children and adolescents were found to have ME/CFS at a rate of 60 cases per 100,000. A second study in 2006 (Jason) "...found the prevalence of pediatric ME/CFS among the general adolescent population to be about...1.8 out of each 1,000 American children." (CFIDS Chronicle, Summer 2007) This rate makes pediatric ME/CFS more prevalent than sickle cell anemia, pediatric heart disease, and Down's syndrome among children.

Most child and adolescent cases are endemic—that is, the illness strikes an individual and not a cluster of individuals in geographic or social proximity. However, epidemic cases do occur, notably an epidemic in Lyndonville, N.Y. from 1984-1987, in which many children in a small, upstate NY community became sick during the same time period. Sometimes, a sibling or parent would also become ill. (Much earlier episodic outbreaks before 1960 were often associated with epidemics of unusual versions of "atypical mild polio".)

Prior to 2006, especially before 2003 when the ME/CFS Canadian definition was published, children and adolescents were diagnosed in the United States by either the 1988 or the 1994 CDC adult definitions. In England, many children were, unfortunately, diagnosed according to the entirely faulty Oxford definition. In 1997, in the Netherlands, a case definition was proposed "in order to increase coherence in child ME/CFS" (DeJong et al.). The 2003 Canadian definition proposed, in a short section, that children could be diagnosed if their symptoms lasted more than 3 months—as opposed to the adult 6-month standard.


The need for a specific Pediatric Case Definition for children and adolescents

Despite the diagnostic improvement provided by the 2003 adult Canadian definition, the lack of a specific ME/CFS diagnostic criteria for children and adolescents continued to create very serious problems. Except for a few clinicians, including Dr. David Bell in Lyndonville, New York, ME/CFS researchers and clinicians knew even less about many of the specific aspects of pediatric ME/CFS than they knew about the adult illness.

The lack of any diagnostic criteria defining and substantiating the illness in children certainly did nothing to support the recognition of the existence of pediatric ME/CFS. The defining and naming of an illness gives validation to its existence—moreover such validation provides an incentive to medical research, and research provides further validation.

Dr. Leonard Jason (a pioneer in pediatric ME/CFS) and Nicole Porter in the CFIDS Chronicle, Summer 2007 summed up the problems stemming from the lack of a specific pediatric case definition:

"Due to the lack of understanding and the long absence of a clear, pediatric-specific case definition for the illness, under-diagnosis or medical misunderstanding can lead to long-term developmental impediments not directly related to the physiological disorder."

"For example, without a clearly defined medical explanation for frequent absences and academic challenges, the skepticism, marginalization and punitive measures taken by many school districts and local judicial systems have caused additional problems for many families already dealing with the immediate difficulties associated with this illness."

"Disturbingly, these diagnostic problems sometimes lead to juvenile truancy charges and even allegations of parental abuse and neglect. This makes the misdiagnosis and under-diagnosing of pediatric ME/CFS a critical issue—forcing a family to negotiate the continuous compromises to the child's physical health, while also struggling against a system that doesn't understand and validate the illness and special issues the child faces."

In addition to these many difficulties, "The lack of application of a consistent pediatric definition of ME/CFS and the lack of a reliable instrument to assess it...might lead to studies which inaccurately label children with a wide variety of symptoms as having ME/CFS as well as possibly missing children who have it." (Jason et al, "A Pediatric Case Definition for ME/CFS", JCFS 13 No. 2/3 (2006).)

Misdiagnosis of children with ME/CFS as being "merely" depressed, as having a school phobia, psychosis, "attention needs", etc. is made even more probable without a validating diagnosis.


Where to find the Pediatric Case Definition for ME/CFS

By 2006, the International Association of Chronic Fatigue Syndrome Working Group for a ME/CFS Pediatric Definition developed and published (in the Journal of Chronic Fatigue Syndrome, v. 13 n.2/3, 2006) a comprehensive "Pediatric Case Definition for Myalgic Encephalomyelitis and Chronic Fatigue Syndrome." The paper also included an instrument (a comprehensive questionnaire) that doctors and other professionals can use to specifically assess ME/CFS in children.

The International Association of CFS, (now the International Association of CFS/ME) is the international group of ME/CFS researchers and clinicians. Under its auspices, a number of the leading researchers and clinicians in the field of pediatric ME/CFS came together to develop the definition. These included: Dr. Leonard Jason, Dr. David Bell, Dr. Charles Lapp, Dr. Karen Jordan, Dr. Kenny de Meirlier, and Dr. Alan Gurwitt (a long-time member of the Massachusetts CFIDS/ME & FM Association), along with other experts.

Read the full 2006 pediatric ME/CFS definition

In 2008, a slightly revised version of the 2006 pediatric case definition was published:

Jason et al., "A Case Definition for Children with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome," in Clinical Medicine: Pediatrics 1, (2008): 53-57.

This shorter and revised version can be viewed here. (The 2006 definition is the most comprehensive, along with its assessment instrument; but the 2008 version is probably more readable and usable for general pediatricians. Updated revisions in the 2008 version will be noted below.)

There is a helpful activity questionnaire and diagnostic checksheet for clinicians.

The 2006 Pediatric Case Definition includes sections: "Diagnosis and Prognosis", ‘Differentiate between Diagnoses", "Prevalence of Pediatric ME/CFS", "Changes from the Adult Definition", "Clarification of Diagnostic Criteria", "Psychological Instruments", "Interventions to Increase Quality of Life", and "Suggestions for Future Research on Pediatric ME/CFS". The entire article is 23 pages, although the diagnostic criteria list is 2 ½ pages. We will present a brief summary of the criteria below.

The definition itself contains elements of the 1994 CDC adult case definitions along with the 2003 Reeves et al. revisions. However, the structure of the 2003 Canadian adult ME/CFS definition is prominently incorporated into the new pediatric definition—thereby giving additional weight to symptoms based not exclusively on fatigue.

During the diagnostic process, the doctor "must carry out a thorough evaluation, including a comprehensive medical and developmental history, physical examination and laboratory tests to confirm diagnosis. The history should involve both parents as well as the child..."


Pediatric Case Definition for ME/CFS

Diagnostic criteria summary:

A child (person under 12-13) or adolescent (12-13 to adult) to be diagnosed with pediatric ME/CFS will meet the following criteria:

1. "Clinically evaluated, unexplained, persistent or relapsing chronic fatigue over the past 3 months that:

a) "Is not the result of ongoing exertion [this does not include the child with pediatric ME/CFS who may become exhausted after minimal exertion];"

b) "Is not substantially alleviated by rest [in the pediatric ME/CFS patient, rest may provide some relief, but not eliminate the syndrome—furthermore even minimal exertion may quickly lead to renewed sickness.]"

c) "Results in substantial reduction in previous levels of educational, social and personal activities"

d) "Must persist or recur for at least all three months." [This requirement is "operationalized" by assessing 'how often the patient has experienced the symptom over the past 3 months on a 7 point scale: 1=hardly ever to 7=every day; to meet the above requirement a score of at least 4 would be indicated."]

2. "The concurrent occurrence of the following classic ME/CFS symptoms, which must have persisted or recurred during the past 3 months of illness (symptoms may predate the reported onset of fatigue)."

a) "Post-exertional malaise...with loss of physical or mental stamina, rapid muscle or cognitive fatigability."

b) "Unrefreshing sleep, or disturbance of sleep quantity or rhythm."

c) "The young person has at least one symptom from any of the following:

1) myofascial pain, 2) joint pain, 3) abdominal and/or 4) head pain"

d) The occurrence of "two or more neurocognitive manifestations, including impaired memory, difficulty focusing, difficulty finding the right word, frequently forgetting what wanted to say, absent-mindedness, slowness of thought, difficulty recalling information, need to focus on one thing at a time, trouble expressing thought, difficulty comprehending information, frequently lose train of thought, new trouble with math or other educational subjects."

e) "Finally, the fifth symptom category requires at least one symptom from two of the following 3 subcategories:

1) autonomic manifestations (neurally-mediated hypotension, postural orthostatic tachycardia, dizziness, shortness of breath, palpitations with or without cardiac arrhythmias, feeling unsteady on the feet—disturbed balance..."(see complete list via link)

2) "neuroendocrine manifestations (recurrent...feverishness and cold extremities, subnormal body temperature...sweating episodes, intolerance of heat and cold, marked weight change—loss of appetite or abnormal appetite, worsening of symptoms with stress."

3) "immune manifestations (recurrent flu-like symptoms, non-exudative sore or scratchy throat, repeated fevers and sweats, lymph nodes tender to palpitation—generally minimal swelling...new sensitivities to food, odors, or chemicals."

"Note: In about 25% of pediatric cases, the onset of the illness is insidious (slowly over time) rather than acute."


Other stipulations

This case definition includes a number of further qualifications and quantifying criteria.

The diagnostic criteria stipulates that "each of the symptoms be either moderate or severe." The following rating scale is to be used by the diagnosing physician: "1= not present, 3= moderate, 7 = severe. Symptoms need to be rated at moderate or severe...to meet criteria."

Also, the definition includes a method for assessing "illness severity and remission states": "(A) minimal (just enough symptoms to meet the diagnosis, particularly occurring with exertion, usually able to attend school); (B) mild (few symptoms in excess of those of the diagnosis, occurring even at rest—may be able to attend school part of the time); (C) moderate (many symptoms in excess of those in the diagnosis, moderate symptoms at rest that become severe with effort—unable to attend school); (D) severe (often housebound or bed bound); (E) in partial remission (full criteria...were previously met, but currently only a few symptoms remain with effort—able to attend school regularly); (F) in full remission (no longer any symptoms, even with effort—able to attend school)."

Exclusionary Conditions

The diagnostic criteria also note separate diagnoses that would exclude a finding of pediatric ME/CFS  (unless they had been separately and successfully treated).

a) These include: "untreated hypothyroidism, sleep apnea, narcolepsy, malignancies, leukemia, unresolved hepatitis, multiple sclerosis, juvenile rheumatoid arthritis, lupus erythematosus, HIV/AIDS, severe obesity... Lyme disease, celiac disease."

b) "Some active psychiatric conditions that may explain the presence of chronic fatigue such as: childhood schizophrenia or psychotic disorders; bipolar disorder; active alcohol abuse unless it has been successfully treated and resolved; active anorexia nervosa or bulimia nervosa, unless it has been treated and resolved."

c) "depressive disorders" -Special note: These are depressive disorders not related to, or secondary to the pediatric ME/CFS. These exclusionary depressive disorders must also adequately explain the physical symptoms. Please see the differential diagnosis section below.

 


Conditions that may co-exist with Pediatric ME/CFS (co-morbid conditions)

The child or adolescent may have concomitant disorders "that do not explain fatigue, and are, therefore, not necessarily exclusionary: (a) psychiatric diagnoses such as school phobia, separation anxiety, anxiety disorders, somatoform disorders, depressive disorders."

Also, a child with pediatric ME/CFS may also concurrently have fibromyalgia and/or multiple food and chemical sensitivity. See the full pediatric definition for further concomitant illnesses.


Differential diagnoses with Pediatric ME/CFS

Often pediatric ME/CFS is misdiagnosed as a psychiatric or behavioral disorder. These disorders include depression, anxiety, and school phobia—among others. However, a child or adolescent may actually have these disorders rather than pediatric ME/CFS.

It is critical for the diagnosing physician to determine if the child or adolescent actually has pediatric ME/CFS (even if these psychiatric or behavioral disorders coexist with the illness), or if the child does not have pediatric ME/CFS but is suffering exclusively with a psychiatric and/or behavioral disorder.


Psychiatric and Behavioral Diagnoses and ME/CFS

First, it should be noted that "somatization disorder that meets the DSM-IV criteria is rare in this age group", i.e., children and adolescents.

Depression

The pediatric criteria makes clear that depression of any diagnostic category may be a symptom of, or even co-exist, with childhood or adolescent ME/CFS. Depression is less common in childhood as opposed to adolescence, and symptoms may be different in the two age groups. Since symptoms of depression may co-exist with ME/CFS, the diagnosing physician must conduct a careful evaluation of the "differing developmental presentations...Inquiring about hobbies and leisure activities is important in distinguishing depression" and pediatric ME/CFS. Those with the physical illness will likely have abandoned their hobbies and leisure activities. Much of the concomitant depression in ME/CFS comes from "underlying frustration as a result of losing control rather than a negative self-image."

Falling behind in school with no recognition of their illness and with no extra help or support—and thereby having to struggle to catch-up—will often lead to depression and anxiety. Moreover, the isolation and loss of friendships and peer activity can lead to depression.

One primary way to differentiate between ME/CFS with depression, as opposed to a separate depressive illness, is to look carefully at symptoms. Depression itself is unlikely to cause multiple symptoms such as sore throats, swollen lymph nodes, fevers, etc. If a diagnosis of depression better explains the child's fatigue and symptom patterns, then depression may be the appropriate diagnosis as opposed to ME/CFS.

School phobia and separation anxiety

When school phobia and separation anxiety predate the fatigue and other symptoms, it is possible that the child does not have ME/CFS and the symptoms are better explained by either of these diagnoses. "Children with school phobia may be differentiated from children with ME/CFS in that the former typically feel ill in the morning but recover once allowed to remain at home from school...In contrast, children and adolescents with ME/CFS would experience symptoms not only at school, but in other settings." Those with school phobia only would not usually have symptoms on weekends or school holidays.

The definition also contains a short discussion as to whether the child might be exhibiting symptoms due to family dysfunction as opposed to ME/CFS. A child with symptoms clearly aimed at holding a family together would not be diagnosed with ME/CFS—however a child truly ill with ME/CFS might be living in an unhealthy family system.


Psychological instruments used in assessment of ME/CFS

The definition provides a discussion and listing of instruments used to assess co-morbid psychiatric conditions, sleep disturbance, and physical and psychological well-being.

Pediatric Health Questionnaires

There are activity questionnaires which are helpful in diagnosing pediatric ME/CFS. "It is generally recommended that adolescents age 12 and over fill it out themselves, and parents can assist or fill it out for children under 11..." More than one person may fill out the questionnaires—child, parents, caregivers, etc. Some clinicians feel that both parents should fill out the forms, since the view of one parent may be limited. Research has also shown that the parents' perceptions of the illness may vary from those of the child. There is also a check-sheet for clinicians making a diagnosis from the ME/CFS: A Primer for Practitioners, as well as a "Functional Capacity Scale".


2008 Revised Pediatric Definition

In 2008, "A Case Definition for Children with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome" was published in Clinical Practice: Pediatrics 1, (2008): 53-57. Most of the articles' authors were the same who wrote the 2006 definition.

This 2008 definition is the same as the 2006 definition, except for a few small revisions.

In the revised criteria, a separate category was established for those children and adolescents who met "almost all the criteria, and they were classified with the Moderate ME/CFS Clinical criteria. To meet this criteria, the patient has to meet four out of the five classic ME/CFS symptoms with frequency and severity ratings of moderate or severe...In addition, for autonomic, neuroendocrine, and immune manifestations, adolescents had to have at least one symptom in any of the 3 categories..."

The revised definition also set up some other subcategories for those with idiopathic chronic fatigue—see the 2006 definition. One subtype in this category is Atypical ME/CFS, which is defined "as 3 or more months of fatigue, but missing more than one classic ME/CFS symptoms...Another category involves Pediatric ME/CFS-like illness, which is defined at meeting all classic ME/CFS symptom criteria, except for the 3-month duration or when one is lacking a medical evaluation."


More Resources

A Son's Road to Recovery

Developmental Issues in Adolescents with CFIDS—A Parent's Thoughts

On the Morbid Fascination with Psychiatric Morbidity

Planning Ahead for the Next School Year

Teenage CFIDS--A Personal Story

 

 

1988 CDC CFS/ME Diagnostic Criteria

The first U.S. Case Definition for the Chronic Fatigue Syndrome (CFS) was published by researchers under the auspices of the Centers for Disease Control & Prevention (CDC) in 1988 in the prestigious journal Annals of Internal Medicine. The case definition is as follows:

"A case of the chronic fatigue syndrome must fulfill major criteria 1 and 2, and the following minor criteria: (a) 6 (or more) of the 11 symptom criteria and 2 (or more) of the 3 physical criteria; or (b) 8 (or more) of the symptom criteria."

Major Criteria

  1. "New onset of persistent or relapsing, debilitating fatigue or easy fatigability in a person who has no previous history of similar symptoms, that does not resolve with bed rest, and that is serious enough to reduce or impair average daily activity below 50% of the patient's premorbid activity level for a period of at least six months."
  2. "Other clinical conditions that may produce similar symptoms must be excluded by thorough evaluation based on history, physical examination, and appropriate laboratory findings. These conditions include malignancies, autoimmune disease, localized infection (such as occult abscess); chronic or subacute bacterial disease (such as endocarditis, Lyme disease, or tuberculosis), fungal disease (such as histoplasmosis, blastomycosis, or coccidiodomycosis), and parasitic disease (such as toxoplasmosis, amebiasis, giardiasis, or helminthic infestation); disease related to human immunodeficiency virus (HIV) infection;"

"...chronic psychiatric disease, either newly diagnosed or by history (such as endogenous depression; hysterical personality disorder; anxiety neurosis, schizophrenia..."

[Comment: These psychiatric diagnoses as a basis for exclusion of a CFS diagnosis were substantially removed from the 1994 CDC definition, especially those not related to major mental illness. The 1994 Definition recognized that anxiety and secondary depression were likely to occur as a result of chronic physical illness. This is one of the few elements of the 1988 definition that was improved in the 1994 definition.]

 

"...or chronic use of major tranquilizers, lithium, or antidepressive medication); chronic inflammatory disease (such as sarcoidosis, Wegener granulomatosis, or chronic hepatitis); neuromuscular disease (such as multiple sclerosis or myasthenia gravis); endocrine disease (such as hypothyroidism, Addison's disease, Cushing Syndrome, or diabetes mellitus); drug dependency or abuse (such as alcohol; controlled prescription drugs, or illicit drugs); side effects of a chronic medication or other toxic agent (such as a chemical solvent, pesticide, or heavy metal); or other known or defined chronic pulmonary, cardiac, gastrointestinal, hepatic, renal, or hematologic disease."

Lab Tests:

"Specific lab tests or clinical measurements are not required to satisfy the definition of chronic fatigue syndrome, but the recommended evaluation includes serial weight measurements...serial morning and afternoon temperature measurements; complete blood count and differential; serum electrolytes; glucose; creatinine; blood urea nitrogen; calcium, phosphorous; total bilirubin; alkaline phosphatase; serum aspartate aminotransferase, serum alanine aminotransferase; creatine phosphokinase or aldolase; urinanalysis...personal and family psychiatric history ...erythrocyte sedimentation rate; antinuclear antibody; thyroid stimulating hormone level; HIV antibody measurement;...and PPD skin test with controls."

"If any of the above are abnormal, the physician should search for other conditions that may cause such a result. If no such conditions are detected by a reasonable evaluation, this criterion is satisfied."

Minor Criteria

Symptom Criteria

 

"To fulfill a symptom criterion, a symptom must have begun at or after the time of onset of increased fatigability, and must have persisted or recurred over a period of at least six months. (Individual symptoms may or may not have occurred simultaneously.) Symptoms include:

Mild fever—oral temperature between 37.5 C and 38.6 C if measured by the patient—or chills. (Note: oral temperatures of greater than 38.6 C. are less compatible with chronic fatigue syndrome and should prompt studies for other causes of illness.)

  1. Sore throat
  2. Painful lymph nodes in the anterior or posterior cervical or axillary distribution
  3. Unexplained generalized muscle weakness
  4. Muscle discomfort or myalgia
  5. Prolonged (24 hours or greater) generalized fatigue after levels of exercise that would have been easily tolerated in the patient's premorbid state
  6. Generalized headaches (of a type, severity, or pattern that is different from headaches the patient may have had in the premorbid state)
  7. Migratory arthralgia without joint swelling or redness
  8. Neuropsychologic complaints (one or more of the following: photophobia, transient visual scotomata, forgetfulness, excessive irritability, confusion, difficulty thinking, inability to concentrate, depression)
  9. Sleep disturbance (hypersomnia or insomnia)
  10. Description of the main symptom complex as initially developing over a few hours to a few days (this is not a true symptom, but may be considered as equivalent to the above symptoms in meeting the requirements of the case definition.)"

 

Physical Criteria

"Physical criteria must be documented by a physician on at least two occasions, at least one month apart.

  1. Low grade fever—oral temperature between 37.6 degrees C and 38.6 degrees C or rectal temperature between 37.8 C and 38.8 C.
  2. Nonexudative pharyngitis.
  3. Palpable or tender anterior or posterior cervical or axillary lymph nodes. (Note: lymph nodes greater than 2 cm in diameter suggest other causes. Further evaluation is warranted)."

 

More resources

1994 CDC definition

2003 Canadian definition

Critique of the 1994 CDC definition

History of ME/CFS/CFIDS


1994 CDC Definition

The Primary U.S. Case Definition

The major case definitions and diagnostic criteria for the Chronic Fatigue Syndrome (CFS) were developed from clinical experience and medical research over the past two decades in the United States, Canada, Australia and Europe.

In the United States, the case definition in most widespread use in 2012 was developed in 1994 under the auspices of the U.S. Centers for Disease Control & Prevention (CDC), the primary federal public health agency.

The Criteria were published as an article, "The Chronic Fatigue Syndrome: A Comprehensive Approach to its Definition and Study" in 1994 in the Annals of Internal Medicine, a prestigious medical journal. This definition identified the illness as "Chronic Fatigue Syndrome"—the name the CDC gave to the illness in its first CFS definition in 1988. (Hence the 1994 criteria are termed the "revised" definition.)

This definition remains the "official" and "authoritative" definition of the U.S. public health and research agencies and is the one most widely distributed among and subscribed to by many researchers and clinicians in the U.S. and other countries.

The CDC diagnostic criteria are also the standard used by the U.S. Social Security Administration (SSA) in determining ME/CFS disability, although in 2014 it issued a ruling accepting the 2003 Canadian criteria as well as some of the 2011 International Consensus Criteria. (See the article "Major 2014 Social Security Ruling.")

To date, in our opinion the 2003 Canadian Definition is the most medically accurate and detailed case definition available to physicians and patients. A patient and his/her physician will best determine presence of the illness using the Canadian Diagnostic Criteria.

So we suggest the that the 1994 Case Definition and the subsequent 2006 CDC Guidelines (an abridgement of the 1994 case definition) not be used as the sole method of diagnosing a case of the Myalgic Encephalomyelitis/chronic Fatigue Syndrome (ME/CFS).


CDC Guidelines for the evaluation and study of CFS

The Centers for Disease Control website presents a summarized version of the 1994 definition (originally published in the 1994 Annals of Internal Medicine) at their site: http://www.cdc.gov/cfs/case-definition/1994.html .

As a reference guide, it is useful to print out the summarized version. Patients may also want to give a copy to their physicians.

In 2010 and 2012, the CDC substantially improved its website information on the CFS diagnostic process. Patients and Health Care Professionals should review the CDC website's most comprehensive explanation of the diagnostic process.

  1. Diagnosis (http://www.cdc.gov/cfs/diagnosis/index.html)—this section of the CDC website covers the following topics: Diagnostic challenges, Exams and Screening Tests for CFS, and Criteria for Diagnosing CFS. It also includes information for patients who think they might have CFS.
  2. Diagnostic Tests to Exclude Other Causes (http://www.cdc.gov/cfs/diagnosis/testing.html)—this section includes tests that will exclude other causes of fatiguing illness and diagnose illness other than CFS.

For the ease of our readers, we are making these sections available here; however, patients may wish to print-out the information at CDC web pages for their providers. 


Diagnosis

Diagnostic Challenges

For doctors, diagnosing chronic fatigue syndrome (CFS) can be complicated by a number of factors:

  1. There's no lab test or biomarker for CFS.
  2. Fatigue and other symptoms of CFS are common to many illnesses.
  3. For some CFS patients, it may not be obvious to doctors that they are ill.
  4. The illness has a pattern of remission and relapse.
  5. Symptoms vary from person to person in type, number, and severity.

These factors have contributed to a low diagnosis rate. Of the one to four million Americans who have CFS, less than 20% have been diagnosed.

Exams and Screening Tests for CFS

Because there is no blood test, brain scan, or other lab test to diagnose CFS, the doctor should first rule out other possible causes.

If a patient has had 6 or more consecutive months of severe fatigue that is reported to be unrelieved by sufficient bed rest and that is accompanied by nonspecific symptoms, including flu-like symptoms, generalized pain, and memory problems, the doctor should consider the possibility that the patient may have CFS. Further exams and tests are needed before a diagnosis can be made:

  • A detailed medical history will be needed and should include a review of medications that could be causing the fatigue and symptoms
  • A thorough physical and mental status examination will also be needed
  • A battery of laboratory screening tests will be needed to help identify or rule out other possible causes of the symptoms that could be treated
  • The doctor may also order additional tests to follow up on results of the initial screening tests

A CFS diagnosis requires that the patient has been fatigued for 6 months or more and has 4 of the 8 symptoms for CFS for 6 months or more. If, however, the patient has been fatigued for 6 months or more but does not have four of the eight symptoms, the diagnosis may be idiopathic fatigue.

For Doctors and Other Healthcare Professionals: Criteria for Diagnosing CFS

Consider a diagnosis of CFS if these three criteria are met:

1.  The individual has severe chronic fatigue for 6 or more consecutive months that is not due to ongoing exertion or other medical conditions associated with fatigue (these other conditions need to be ruled out by a doctor after diagnostic tests have been conducted)
2.  The fatigue significantly interferes with daily activities and work
3.  The individual concurrently has 4 or more of the following 8 symptoms:

  • post-exertion malaise lasting more than 24 hours
  • unrefreshing sleep
  • significant impairment of short-term memory or concentration
  • muscle pain
  • multi-joint pain without swelling or redness
  • headaches of a new type, pattern, or severity
  • tender cervical or axillary lymph nodes
  • a sore throat that is frequent or recurring

For Patients Who Think They Might Have CFS

It can be difficult to talk to your doctor or other health care professional about the possibility that you may have CFS. A variety of health care professionals, including doctors, nurse practitioners, and physician assistants, can diagnose CFS and help develop an individualized treatment plan for you.

CFS can resemble many other illnesses, including mononucleosis, Lyme disease, lupus, multiple sclerosis, fibromyalgia, primary sleep disorders, and major depressive disorder. Medications can also cause side effects that mimic the symptoms of CFS.

Because CFS can resemble many other disorders, it's important not to self-diagnose CFS. It's not uncommon for people to mistakenly assume they have chronic fatigue syndrome when they have another illness that will respond to treatment. If you have CFS symptoms, consult a health care professional to determine if any other conditions are responsible for your symptoms. A CFS diagnosis can be made only after other conditions have been excluded.

It's also important not to delay seeking a diagnosis and medical care. CDC research suggests that early diagnosis and treatment of CFS can increase the likelihood of improvement.


Diagnostic tests to exclude other causes

Tests for Routine Diagnosis of CFS
While the number and type of tests performed may vary from doctor to doctor, the following tests constitute a typical standard battery to exclude other causes of fatiguing illness:

  • alanine aminotransferase (ALT)
  • albumin, alkaline phosphatase (ALP)
  • blood urea nitrogen (BUN)
  • calcium
  • complete blood count with differential
  • creatinine
  • electrolytes
  • erythrocyte sedimentation rate (ESR)
  • globulin
  • glucose
  • phosphorus
  • thyroid stimulating hormone (TSH)
  • total protein
  • transferrin saturation
  • urinalysis

Further testing may be required to confirm a diagnosis for illness other than CFS. For example,
• If a patient has low levels of serum albumin together with an above-normal result for the blood urea nitrogen test, kidney disease would be suspected. The doctor may choose to repeat the relevant tests and possibly add new ones aimed specifically at diagnosing kidney disease.
• If autoimmune disease is suspected on the basis of initial testing and physical examination, the doctor may request additional tests, such as for antinuclear antibodies.

Assessing the Impact of Fatigue on Cognition
For some patients, it may be beneficial to conduct tests to assess how fatigue is affecting their cognitive skills such as concentration, memory, and organization. This additional testing can be useful in the differential diagnosis process or in identifying specific areas in which therapy may help. This may be particularly helpful to children and adolescents with CFS. Academic attendance and performance are important in these patients, and their specific educational needs should be addressed.

Tests for Differential Diagnosis and Management
CFS remains a diagnosis based on medical history, illness symptoms, physical examination, and exclusion of certain illnesses using a standard group of laboratory tests (1994 case definition). Additional tests such as imaging and physiological assessments can also be used to diagnose underlying illnesses:
• specific cultures or serological tests if an ongoing infection is considered
• MRI or other neuroimaging procedures to test for diseases such as multiple sclerosis
• physiological testing such as sleep studies, exercise testing (including VO2 max), or tilt table testing to address specific questions, often in consultation with a specialist

Be aware that a patient can have CFS as well as a co-existing illness that cause fatigue or other CFS symptoms—for example, depression or low blood pressure. If treatment of those other illnesses does not resolve the symptoms, then the person can still have CFS.


Assessment of the 1994 CDC Definition

Recently, the CDC has very substantially improved its guidelines for the application of the 1994 CFS Criteria, and the Agency has stated it is reviewing the efficacy of more recent Diagnostic Criteria.

The CDC Criteria had very substantial flaws at its inception, so it is helpful to review both (1) some supplemental lab tests available to physicians for diagnostic purposes, and (2) the substantial limitations of the Criteria in accurately diagnosing ME/CFS.

Other Laboratory testing: Given more recent research and clinical experience, as well as the Social Security Administration Ruling on CFS, 2014, other tests may be indicative of CFS. A number CFS expert researchers and clinicians have developed protocols of laboratory and other tests that are helpful in adding confirmatory weight to a ME/CFS diagnosis. These tests are not directly diagnostic; however, in a percentage of cases they can positively contribute to a diagnosis after all other steps are taken under various diagnostic criteria.

It should be noted that in other sections of this website are references to various recent papers which provide evidence of viral and other microbial involvement in ME/CFS. Experienced clinicians and researchers are beginning to make use of various tests to determine the presence of active virus, including EBV, CMV, HHV-6, as well as other microbes. Clinicians certainly can run the protocols below as part of their effort to diagnose ME/CFS.

Dr. Anthony Komaroff, a leading specialist in ME/CFS cites the following laboratory abnormalities as supportive of a ME/CFS diagnosis:

Laboratory Abnormalities and Chronic Viral Fatigue Syndrome (CFS)*:

  • Mild leukopenia (3000-5000/mm)
  • Moderate monocytosis (7%-15%)
  • Relative lymphocytosis (>40%)
  • Atypical lymphocytosis (1%-20%)
  • Slight elevation in SGOT and SGPT
  • Erythrocyte sedimentation rate unusually low (0-4mm)
  • Partial reduction in immunoglobulins
  • Circulating immune complexes (low levels)
  • Increased CD4/CD8 ratio
  • EBV antibodies:

Viral capsid antigen-IgG > 1:640
Viral capsid antigen-IgM-not detectable
Early antigen- 1:40
EB nuclear antigen <1:5

*It is unusual for more than one or two of these findings to be present in any single patient. 


Flaws in the 1994 Case Definition

The 1994 CDC definition, unfortunately, has proven to be partially flawed. First, the Criteria was originally intended as a research definition and for that reason excluded CFS cases that might have certain dual diagnoses, for instance CFS and obesity and CFS and bi-polar disorder.

The CFS definition, however, had come into wide use clinically—that is to diagnose patients in normal medical settings. Hence, a number of research exclusions would prevent patients, with additional diagnoses, from properly receiving a CFS diagnosis. To its credit the CDC has currently recognized this problem.

The CDC definition refers to a "mental status examination". In the past, many physicians have been unclear as to how, and by whom, such an examination should be performed. The CDC now suggests this exam can be performed by the patient's examining physician.

The 1994 Criteria, itself, does not with acceptable accuracy, clinically identify and distinguish the actual illness. (This has been shown in convincing research studies. See some references mentioned in the Canadian Guidelines booklet). For this reason, research results that use the 1994 definition may also be flawed, as some subjects who do not have the illness are invariably included.

The 1994 definition puts too much emphasis on the existence of a major symptom—fatigue—while not taking into sufficient account other major symptom complexes or the peculiar characteristics of the fatigue (which include post-exertional malaise mimicking that found in mitochondrial disease occurring the day after minor exertion).

The definition clouds the now research-validated difference between psychiatric illnesses and the multi-systemic, physiological, and coherent disease entity which is ME/CFS—an illness with common immune, endocrine, cardiovascular, and neurological dysfunction.

More and more research is also identifying the involvement of viruses and other potential microbes, as well as involvement of the RNase-L system in cells. The 1994 definition is diagnostically not sufficiently rigorous as it permits the misdiagnosis of individuals with psychiatric illness as having ME/CFS, and conversely, permits individuals who actually have ME/CFS to be misdiagnosed as having psychiatric illness.

Moreover, the name itself, Chronic Fatigue Syndrome, is inaccurate and not only distorts the medical nature of the illness but also badly serves a real understanding of the illness by patients, physicians and the general public. Many of the U.S. and international researchers most knowledgeable about the illness clearly recognize the deficiencies of the case definition and the 1994 diagnostic criteria.

In an attempt to overcome the harm created by the name Chronic Fatigue Syndrome, patients in the United States, beginning in the early 1990s, have termed the illness Chronic Fatigue Immune Dysfunction Syndrome (CFIDS), since immune abnormalities in patients have been demonstrated by many definitive research studies. In 2012, the patient community in the United States has been advocating to the federal agencies the use of the name Myalgic Encephalomyelitis.

For a more detailed analysis of the flaws in the 1994 CDC Definition, see Critique of the CDC Case Definitions and  Detailed explanation of the 1994 CFS Definition . 


When the 1994 CDC Case Definition should be used

There are a number of situations in which the patient will clearly need a diagnosis that relies upon the 1994 CDC definition. This definition is the only one recognized by some long-term disability insurance companies, and other agencies providing financial, medical, housing and food assistance. In these cases, diagnosis according to both the 2003 Canadian definition and the 1994 CDC definition is preferable, and the doctor may rely on the 1994 definition in providing disability documentation. 

Subcategories

Notice about names

The Massachusetts ME/CFS & FM Association would like to clarify the use of the various acronyms for Chronic Fatigue Syndrome (CFS), Chronic Fatigue & Immune Dysfunction Syndrome (CFIDS) and  Myalgic Encephalomyelitis (ME) on this site. When we generate our own articles on the illness, we will refer to it as ME/CFS, the term now generally used in the United States. When we are reporting on someone else’s report, we will use the term they use. The National Institutes of Health (NIH) and other federal agencies, including the CDC, are currently using ME/CFS. 

Massachusetts ME/CFS & FM Association changed its name in July, 2018, to reflect this consensus.